Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2016 - 2025)

Prestige Consumer Healthcare has reported Cash from Financing Activities over the past 16 years, most recently at -$6.7 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 87.5% year-over-year to -$6.7 million; the TTM value through Dec 2025 reached -$129.5 million, up 45.84%, while the annual FY2025 figure was -$182.1 million, 24.45% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$6.7 million at Prestige Consumer Healthcare, up from -$74.9 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $63.6 million in Q2 2021 and troughed at -$83.7 million in Q1 2021.
  • A 5-year average of -$40.9 million and a median of -$53.7 million in 2023 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 167.11% in 2021 and fell as far as 647.88% in 2021.
  • Year by year, Cash from Financing Activities stood at -$67.6 million in 2021, then surged by 85.18% to -$10.0 million in 2022, then plummeted by 547.07% to -$64.8 million in 2023, then increased by 16.93% to -$53.9 million in 2024, then soared by 87.5% to -$6.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for PBH at -$6.7 million in Q4 2025, -$74.9 million in Q3 2025, and -$36.3 million in Q2 2025.